esophageal cancer
Conditions
Interventions
One month prior to the intervention, a stool sample will be taken to identify the intestinal flora. Based on the results, a personalized Body Granola tailored to each case will be created. The patient
Sponsors
Toranomon Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who underwent ileocolonic reconstruction at our hospital and were diagnosed with chronic diarrhea at their one-year postoperative outpatient visit.
Exclusion criteria
Exclusion criteria: The following cases are excluded Patients with active inflammatory conditions Patients currently taking steroids Patients with poor nutritional status (Geriatric Nutritional Risk Index [GNRI] < 90) Patients with food allergies Patients who do not have a regular breakfast habit or cannot replace breakfast with the test food during the study period Patients currently participating or planning to participate in other clinical trials involving pharmaceuticals or health foods Patients with extremely irregular eating habits Patients who consume alcohol excessively Patients whose lifestyle is expected to change significantly during the study period Patients who cannot drink milk Patients with a history of severe diseases involving the heart, liver, kidneys, or gastrointestinal system Pregnant patients, those planning pregnancy, or those who are breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measures are changes in gut microbiota composition, stool characteristics, laboratory findings, and body composition. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures include changes in mood status and subjective sleep quality. | — |
Countries
Japan
Contacts
Public ContactYusuke Ogawa
Toranomon Hospital Department of Gastroenterological Surgery
Outcome results
None listed